Home / Drug shortages / Oxaliplatin Injection

Oxaliplatin Injection — FDA Drug Shortage

To Be Discontinued — Sandoz Inc.

The FDA lists a drug shortage record for Oxaliplatin Injection (injection) from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on 10/20/2025.

Shortage Details

Status
To Be Discontinued
Company
Sandoz Inc.
Package NDC
0781-3315-70
Dosage Form
Injection
Presentation
Oxaliplatin, Injection, 5 mg/1 mL (NDC 0781-3315-70)
Initial Posting
10/20/2025
Revised Date

FDA data resources